Scientists now confirm that blood tests can monitor the Alzheimer’s Disease. Research has showed that blood testing for certain protein concentrations could be a non-invasive way to monitor Alzheimer’s disease progression.
Can you Track Alzheimer’s Through a Blood Test
The protein is called a light from the neurofilament that spills damaged and dying nerve cells into the cerebrospinal fluid that flows into the bloodstream. Studies have shown that blood concentrations of neurofilament light in individuals with illnesses, such as Alzheimer’s, are greater.
It is feasible that measuring blood concentrations of neurofilament light might demonstrate whether Alzheimer’s treatment drugs work. Before the first symptoms begin to show, measuring neurofilament light in the blood could recognize Alzheimer’s disease 10 years or longer.
How the Brain Changes with Alzheimer’s
Alzheimer’s is a complex disease that can not be diagnosed easily. Approximately 80% of dementia sufferers have Alzheimer’s. The early-arriving symptom of Alzheimer’s is short-term memory loss. An array of other cognitive and physical deterioration resulting from brain cell loss will gradually deteriorate over time. This major decline can cause individuals to lose their independent ability to live and relate to those around them.
The percentage of Americans with Alzheimer’s is large, reaching 5.8 million individuals and it is said that by 2050 numbers will increase to 14 million. Unfortunately, Alzheimer’s disease is not cured, but medications are available to relieve symptoms. Although there are no treatments to prevent the progression of this illness.
Can Blood Tests Detect Alzheimer’s
In those with Alzheimer’s, neurofilament proteins increase overtime along with cumulative brain damage. Brain MRI or lumbar punctures take a lot of time and money, so it can can be a cheaper and easier option to measure neurofilament light in the blood.
Can These Further The Development of Alzheimer’s Research
These experiments can be useful as they can demonstrate if a drug slows down or stops the loss of the brain’s nerve cells. Within drug development, it can be valuable to identify the impacts of the drug being tested at an early point and to be able to test individuals who do not yet have full-blown Alzheimer’s.
It is essential to continue to study neurofilament light as a prospective biomarker for Alzheimer’s disease. For example, questions remain about the sensitivity of the marker and how it will change over the long term. New trials also need to examine the impacts drugs could have on protein concentrations. A blood test using neurofilament light could be here earlier than individuals might believe.
Fairmont Grand Senior Living Community
Fairmont Grand is a resident centered senior living and memory care facility in Rapid City, SD. Our goal is to create an environment where resident well-being is at the heart of everything we do.
Our wide range of services are designed to meet you or your loved one’s daily needs. We offer restaurant style dining options, a variety of physical activities, and give residents the opportunity to live as independently as possible.